Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
N Engl J Med. 2020.
PMID: 32970396
Free article.
Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed]
[No authors listed]
Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597.
Global Spine J. 2023.
PMID: 37222100
Free PMC article.
No abstract available.
Item in Clipboard
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink HJL, Cherney D, Postmus D, Stefánsson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC; DAPA-CKD Trial Committees and Investigators.
Heerspink HJL, et al.
Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22.
Kidney Int. 2022.
PMID: 34560136
Free article.
Clinical Trial.
Item in Clipboard
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators.
Heerspink HJL, et al.
Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094.
Eur Heart J. 2021.
PMID: 33792669
Free PMC article.
Clinical Trial.
Item in Clipboard
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Chee CE, Ooi M, Lee SC, Sundar R, Heong V, Yong WP, Ng CH, Wong A, Lim JSJ, Tan DSP, Soo R, Tan JTC, Yang S, Thura M, Al-Aidaroos AQ, Chng WJ, Zeng Q, Goh BC.
Chee CE, et al.
Target Oncol. 2023 May;18(3):391-402. doi: 10.1007/s11523-023-00962-w. Epub 2023 Apr 15.
Target Oncol. 2023.
PMID: 37060431
Free PMC article.
Clinical Trial.
Item in Clipboard
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.
Ong SY, Chin YA, Than H, Tan CW, Yap ES, Wong WH, Ng HJ.
Ong SY, et al.
Ann Hematol. 2017 Mar;96(3):525-527. doi: 10.1007/s00277-016-2871-z. Epub 2016 Nov 7.
Ann Hematol. 2017.
PMID: 27822611
No abstract available.
Item in Clipboard
Cite
Cite